The use of drugs in mothers of offspring with neural-tube defects

Pharmacoepidemiology and Drug Safety

Volumn 13, Issue 7, 2004, Pages 443-455

  Medveczky, Erika ^a,b   Puhó, Erzsébet ^a,b   Czeizel, E Andrew ^a,b  

^a International Petö Institute   (Hungary)

^b FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

Author keywords

Carbamazepine; Human teratogenic potential; Maternal drug use; Neural tube defects; Oxytetracycline; Recall bias; Valproic acid

Indexed keywords

ACETYLSALICYLIC ACID; ALLYLESTRENOL; AMINOPHENAZONE; AMINOPHYLLINE; AMPICILLIN; BROMHEXINE; CARBAMAZEPINE; CHORIONIC GONADOTROPIN; CLOMIFENE; CLOPAMIDE; CLOTRIMAZOLE; DIAZEPAM; DIMENHYDRINATE; DROTAVERINE; ERGOTAMINE; ESTROGEN DERIVATIVE; FENOTEROL; HYDROXYPROGESTERONE; LYNESTRENOL; METRONIDAZOLE; NALIDIXIC ACID; NITROFURANTOIN; OXYTETRACYCLINE; PENAMECILLIN; PENICILLIN G; PENICILLIN V; PROMETHAZINE; TERBUTALINE; UNINDEXED DRUG; VALPROIC ACID;

ABORTION; ADULT; ANENCEPHALUS; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG MEGADOSE; DRUG SURVEILLANCE PROGRAM; ENCEPHALOCELE; FEMALE; FIRST TRIMESTER PREGNANCY; HEALTH SURVEY; HUMAN; HUNGARY; MAJOR CLINICAL STUDY; MALE; NEURAL TUBE DEFECT; NEWBORN; OUTCOMES RESEARCH; POPULATION RESEARCH; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; SPINA BIFIDA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STILLBIRTH;

ABNORMALITIES, DRUG-INDUCED; CASE-CONTROL STUDIES; FEMALE; HUMANS; HUNGARY; INFANT, NEWBORN; MALE; MATERNAL-FETAL EXCHANGE; NEURAL TUBE DEFECTS; PREGNANCY; PREVALENCE; REGISTRIES; SUBSTANCE-RELATED DISORDERS;

EID: 3242892579     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.900     Document Type: Article

References (48)

1. Lindquist M. Seeing and Observing in International Pharmacovigilance. Uppsala Monitoring Centre: Uppsala, 2003.
2. Czeizel AE, Révész C. Major malformations of the central nervous system in Hungary. Br J Prev Soc Med 1970; 24: 205-222.
3. Czeizel AE, Dudás I. Prevention of first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327: 1832-1835.
4. Czeizel AE, Petik D, Vargha P. Validation studies of drug exposures in pregnant women. Pharmacoepid Drug Safe 2003; 12: 409-416.
5. Czeizel AE. The first 25 years of the Hungarian Congenital Abnormaltiy Registry. Teratology 1997; 55: 299-305.
6. Van der Put NMJ, Van den Henrel LP, Steegers-Theunissen RPM, et al. Decreased methylenetetrahydrofolate-reductase activity due to the 677C-T mutation in families with spina bifida offspring. J Mol Genet 1996; 74: 691-694.
7. McNulty H, McKinley MC, Wilson B, et al. Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin status: implication for riboflavin requirement. Am J Nutr 2002; 76: 236-241.
8. Czeizel AE. Primary prevention of neural-tube defects and some other major congenital abnormalities. Pediatric Drugs 2000; 2: 437-449.
9. Elwood JM, Little J, Elwood JH. Epidemilogy and Control of Neural Tube Defects. Oxford University Press: Oxford; 1992.
10. Czeizel AE, Rockenbauer M, Siffel CS, Varga E. Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-1996. Teratology 2001; 63: 176-185.
11. Czeizel AE, Intödy ZS, Modell B. What proportion of congenital abnormalities can be prevented? Br Med J 1993; 306: 499-503.
12. Czeizel AE, Tóth M, Rockenbauer M. Population-based case-control study of folic acid supplementation during pregnancy. Teratology 1996; 53: 345-351.
13. Medveczky E, Puho E, Czeizel AE. The evaluation of maternal illnesses in the origin of neural-tube defects. Arch Obstet Gynec (in press).
14. Rockenbauer M, Olsen J, Czeizel AE, Pedersen L, Sørensen HT. Recall bias in a case-control study on the use of medicine during pregnancy: EuroMAP group. Epidemiology 2001; 12: 461-466.
15. Czeizel AE, Rockenbauer M. A population-based case-control teratologic study of oral oxytetracycline treatment during pregnancy. Eur J Obstet Gynec Reprod Biol 2000; 88: 27-33.
16. Gomez MR. Possible teratogenicity of valproic acid. J Pediatr 1981; 95: 508-509.
17. Robert E, Gibaud P. Maternal valproic acid and congenital neural tube defects. Lancet 1982; ii: 937.
18. Bjerkedal T, Czeizel AE, Gonjard J, et al. Valproic acid and spina bifida. Lancet 1982; ii: 1096.
19. Lammer EJ, Seve LE, Oakley GP. Teratogen update: valproic acid. Teratology 1987; 35: 465-473.
20. Rosa FW. Pregnancy outcomes with maternal carbamazepine exposure. In FDA ADR highlights (Document No. 1983-ADR No.11). Food and Drug Administration, Rockville 145D. 1983.
21. Rosa FW. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 1991; 324: 674-677.
22. Czeizel AE, Telegdi L, Tusnády G. Multiple Congenital Abnormalities. Akadémiai Kiadó: Budapest, 1998.
23. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000; 343: 1608-1614.
24. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. Neural-tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol 2001; 153: 961-968.
25. Kasan PN, Andrews J. Oral contraceptives and congenital abnormalities. Br J Obstet Gynaecol 1980; 87: 545-551.
26. Cuckle HS, Wald NJ. Evidence against oral contraceptives as a cause of neural tube defects. Br J Obstet Gynaecol 1982; 89: 547-549.
27. Gal I, Kirman B, Stern I. Hormonal pregnancy tests and congenital malformation. Nature 1967; 216: 83.
28. Sainz MP, Rodriguez Pinilla E, Martinez-Frias ML. Progestagenos y estrogenos a altas dosis (pruebas hormonales de embarazo): riesgo de aparicion de espina bifida y anencefalia. Med Clin (Barc) 1987; 89: 272-274.
29. Laurence KM, Miller M, Vowles M, et al. Hormonal pregnancy tests and neural tube malformations. Nature 1971; 233: 495-496.
30. Oakley GP, Flynt JW, Falek A. Hormonal pregnancy tests and congenital malformations. Lancet 1973; ii: 256-257.
31. Lammer EJ, Cordem JF. Exogenous sex hormone exposure and the risk for major malformations. J Am Med Assoc 1986; 255: 3128-3132.
32. Cornel MC, Ten Kate LP, Dukes MNG, et al. Ovulation induction and neural tube defects. Lancet 1989a; i: 1386.
33. Czeizel AE. Ovulation induction and Dental tube defects. Lancet 1989; ii: 167.
34. Cuckle HS, Wald NJ. Ovulation induction and neural tube defects. Lancet 1989; ii: 1281.
35. Robert E, Predat E, Laumon B. Ovulation induction and neural tube defects: a registry study. Reprod Toxicol 1991; 5: 83-84.
36. Mills JL, Simpson JL, Rhoads GG, et al. Risk of neural tube defects in relation to maternal fertility drug use. Lancet 1990; 336: 103-104.
37. Lancester PAL. Congenital malformations after in-vitro fertilisation. Lancet 1987; ii: 1392-1393.
38. Cornel MC, Ten Kate LP, Te Meerman GJ. Ovulation induction, in-vitro fertilisation and neural tube defects. Lancet 1989b; ii: 1530.
39. MRC Working Party on Children Conceived by In Vitro Fertilisation. Birth in Great Britain resulting from assisted conception, 1978-1987. Br Med J 1990; 300: 1229-1233.
40. Caspi E, Ronen J, Schreyer P, Goldberg MD. The outcome of pregnancy after gonadotrophin therapy. Br J Obstet Gynecol 1976; 83: 967-973.
41. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation (5th edn). Williams and Wilkins: Baltimore, 1998.
42. Mirianthopoulos NC, Melnick M. Studies in neural tube defects. I. Epidemiologic and etiologic aspects. Am J Med Genet 1987; 26: 783-796.
43. Shaw GM, Todoroff K, Velie EM, Lammer EJ. Maternal illness, including fever and medication use as risk factors for neural tube defects. Teratology 1998; 57: 1-7.
44. Czeizel AE. Lack of evidence of teratogenicity of benzodiazepine drugs in Hungary. Reprod Toxicol 1988; 1: 183-188.
45. Czeizel AE. Teratogenicity of ergotamine. J Med Genet 1989; 26: 69-70.
46. Czeizel AE, Dobó M, Vargha P. Hungarian two-cohort study of periconceptional multivitamin supplementation to prevent certain congenital abnormalities. J Am Med Assoc (submitted).
47. Czeizel AE, Rockenbauer M, Sørensen HT, Olsen J. Teratogenic risk of trimethoprim-sulfonamids: a population-based case-control study. Reprod Toxicol 2001; 15: 637-646.
48. Koren G, Graham K, Sheav H, Einarson T. Bias against the null hypothesis: the reproductive hazards of cocaine. Lancet 1989; ii: 1440-1442.